Guangzhou Improve Medical Instruments to IPO on ChiNext

Guangzhou Improve Medical Instruments Co., Ltd, an in-vitro diagnostics company, is scheduled to make its IPO on Shenzhen’s ChiNext exchange. The company has established a price of 25 RMB ($3.67) per share for the offering’s 18.6 million shares, making the IPO worth $68 million for the company. Its major product is evacuated blood collection systems. Improve Medical Instruments is the only life science company among the eight companies involved in ChiNext’s second round. More details...